Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia

Circulation Journal

Volumn 70, Issue 3, 2006, Pages 268-272

  Yuge, Masaru ^a   Niwano, Shinichi ^a   Moriguchi, Masahiko ^a   Sasaki, Takeshi ^a   Hirasawa, Shoji ^a   Imaki, Ryuta ^a   Sato, Daisuke ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiarrhythmic therapy; Electrophysiologic study; Ventricular tachycardia

Indexed keywords

ANTIARRHYTHMIC AGENT; ISOPRENALINE;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; DEFIBRILLATOR; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS; RECURRENCE RISK; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION;

EID: 33644596823     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.70.268     Document Type: Article

References (31)

1. Wilber D, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, et al. Out-of-hospital cardiac arrest: Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988; 318: 19-24.
2. Niwano S, Yamaura M, Yoshizawa N, Moriguchi M, Kitano Y, Aizawa Y, et al. Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study guided effective pharmacological therapy. Jpn Circ J 1999; 63: 674-680.
3. Josephson ME, Horowitz LN. Electrophysiologic approach to therapy of recurrent sustained ventricular tachycardia. Am J Cardiol 1979; 43: 631-642.
4. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmia. N Engl J Med 1997; 337: 1576-1583.
5. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 2000; 342: 1937-1945.
6. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al for the Multicenter Automatic Defibrillator Implantation Trial Investigator. Improved survival with an implanted defibrillator in patients with coronary disease high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933-1940.
7. Niwano S, Aizawa Y, Satoh M, Chinushi M, Shibata A. Low energy electrical ablation for sustained ventricular tachycardia. Am Heart J 1991; 119: 81-88.
8. Aizawa Y, Chinushi M, Naitoh N, Kusano Y, Kitazawa H, Takahashi K, et al. Catheter ablation with radiofrequency current of ventricular tachycardia originating from the right ventricle. Am Heart J 1993; 125: 1269-1275.
9. Gillis AM, Sheldon RS, Wyse DG, Duff HJ, Cassidy MR, Mitchell LB. Clinical and electrophysiologic predictor of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2003; 14: 492-498.
10. Waller TJ, Kay HR, Spielman SR, Kutalek SP, Greenspan AM, Horowitz LN. Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: Criteria of efficacy in patients with sustained ventricular tachyarrhythmia. J Am Coll Cardiol 1987; 10: 83-89.
11. Toda H, Ito S, Naito S, Taniguchi K, Ueda M, Shinbo G, et al. Prevalence and electrocardiographic characteristics of idiopathic ventricular arrhythmia originating in the free wall of the right ventricular outflow tract. Circ J 2004; 68: 909-914.
12. Mitchell LB, Sheldon RS, Gillis AM, Connolly SJ, Duff HJ, Gardner MJ, et al. Definition of predicted effective antiarrhythmic drug therapy for ventricular tachyarrhythmias by the electrophysiologic study approach: Randomized comparison of patient response criteria. J Am Coll Cardiol 1997; 30: 1346-1353.
13. Raitt MH, Dolack GL, Kudenchuk PJ, Poole JE, Bardy GH. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation. Circulation 1995; 91: 1996-2001.
14. Poole JE, Mathisen TL, Kudenchuk PJ, McAnulty JH, Swerdlow CD, Greene HL, et al. Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: Evaluation by electrophysiologic subgroups. J Am Coll Cardiol 1990; 16: 657-665.
15. Stevenson WG, Brugada P, Waldecher B, Zehender M, Wellens HJ. Clinical, angiographic and electrophysiologic findings in patients with aborted sudden death as compared with patients with sustained ventricular tachycardia after myocardial infarction. Circulation 1985; 71: 1146-1152.
16. Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WS, et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989; 13: 1353-1361.
17. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-1940.
18. Zipes DP, Roberts D. Pacemaker-Cardioverter-Defibrillator Investigators: Results of the international study of the implantable pacemaker cardioverter-defibrillator: A comparison of epicardial and endocardial lead system. Circulation 1995; 92: 59-65.
19. The AVID Investigators. Antiarrhythmics versus implantable defibrillators (AVID): Rationale, design, and methods. Am J Cardiol 1995; 75: 470-475.
20. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
21. Swerdlow CD, Peterson J. Prospective comparison of Holter monitoring and electrophysiologic study in patients with coronary artery disease and sustained ventricular tachyarrhythmias. Am J Cardiol 1985; 56: 577-580.
22. Aizawa Y, Murata M, Satoh M, Funazaki T, Matsuoka A, Shibata A, et al. Requirements of non-pharmacologic interventions in the treatment of recurrent sustained ventricular tachycardia. Jpn Circ J 1990; 54: 1340-1348.
23. Niwano S, Furushima H, Taneda K, Abe A, Ohira K, Aizawa Y. The usefulness of Holter monitoring in selecting pharmacological therapy for patients with sustained monomorphic ventricular tachycardia: Studies in patients in whom no effective pharmacologic therapy could be determined by electrophysiologic study. Jpn Circ J 1998; 62: 347-352.
24. Raczak G, Pinna GD, Maestri R, Danilowicz-Szymanowicz L, Szwoch M, Lubinski A, et al. Different predictive values of electrophysiological testing and autonomic assessment in patients surviving a sustained arrhythmic episode. Circ J 2004; 68: 634-638.
25. Aiba T, Kurita T, Taguchi A, Shimizu W, Suyama K, Aihara N, et al. Long-term efficiency of empirical chronic amiodarone therapy in patients with sustained ventricular tachyarrhythmia and structure heart disease. Jpn Circ J 2002; 66: 367-371.
26. Greene HL. The CASCDE study: Randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle: CASCADE investigators. Am J Cardiol 1993; 72: 70-74.
27. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomized trial of low-dose amiodarone in server congestive heart disease: Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994; 344: 493-498.
28. Niwano S, Aizawa Y, Chinushi M, Tamura M, Ishiguro J, Ebe K, et al. Syncope and sudden cardiac death in patients with sustained ventricular tachycardia. Heart 1990; 22(Suppl): 43-48.
29. Brembilla-Perrot B, Suty-Selton C, Alla F, Beurrier D, Houriez P, Claudon O, et al. Risk factors for cardiac mortality in cases of syncope with previous history of myocardial infarction. Arch Mal Coeur Vaiss 2003; 96: 1181-1186.
30. Buxton AE, Marchlinski FE, Waxman HL, Flores BT, Cassidy DM, Josephson ME. Prognostic factors in nonsustained ventricular tachycardia. Am J Cardiol 1984; 53: 1275-1279.
31. Swerdlow CD, Winkle RA, Mason JW. Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med 1983; 308: 1436-1442.